Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Improved Clinical and Microscopy Diagnosis at Primary Health Care in Tanzania
This study has been completed.
Sponsors and Collaborators: Muhimbili University of Health and Allied Sciences
Karolinska Institutet
Information provided by: Muhimbili University of Health and Allied Sciences
ClinicalTrials.gov Identifier: NCT00687895
  Purpose

General objective: To improve the quality of fever case management in children in government health facilities in Tanzania Hypothesis:The training of health workers, as well as provision, training and use of microscopes for malaria diagnosis will improve the treatment of clinical episodes of fever in children while reducing the amount and costs of drugs


Condition Intervention Phase
Malaria
Procedure: Clinical algorithm and microscopy diagnosis of malaria
Phase IV

MedlinePlus related topics: Fever Health Facilities Malaria
Drug Information available for: Benzocaine
U.S. FDA Resources
Study Type: Interventional
Study Design: Health Services Research, Randomized, Open Label, Uncontrolled, Parallel Assignment
Official Title: Quality Malaria Case Management In Under- Fives In Primary Health Care (Phc) Institutions In Bagamoyo And Kibaha Districts Of Coastal Tanzania:a Multicomponent Controlled Intervention Study

Further study details as provided by Muhimbili University of Health and Allied Sciences:

Primary Outcome Measures:
  • the proportion of study children receiving prescriptions of antimalarial drugs in the respective arms [ Time Frame: Day 0 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • prescriptions of antibiotics, cost of drugs [ Time Frame: Day 0 ] [ Designated as safety issue: No ]
  • health outcome of the patients [ Time Frame: Day 1-6, day 7 ] [ Designated as safety issue: No ]

Enrollment: 3131
Study Start Date: July 2003
Study Completion Date: March 2004
Primary Completion Date: March 2004 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
training in clinical algorithm plus microscopy
Procedure: Clinical algorithm and microscopy diagnosis of malaria

Clinical alogarithm

The content of the package included

  1. description of signs and symptoms of malaria disease
  2. history taking relevant to malaria and physical examination
  3. identification of danger signs and severe illness for referral
  4. appropriate treatment
  5. counseling patients on the use of drugs.

Malaria microscopy. contents

  1. make thick blood smears from patients with fever and stain with Giemsa
  2. identify and count malaria parasites
  3. maintain the microscope and store blood slides.
2: Experimental
clinical algorithm
Procedure: Clinical algorithm and microscopy diagnosis of malaria

Clinical alogarithm

The content of the package included

  1. description of signs and symptoms of malaria disease
  2. history taking relevant to malaria and physical examination
  3. identification of danger signs and severe illness for referral
  4. appropriate treatment
  5. counseling patients on the use of drugs.

Malaria microscopy. contents

  1. make thick blood smears from patients with fever and stain with Giemsa
  2. identify and count malaria parasites
  3. maintain the microscope and store blood slides.
3: No Intervention
Control

Detailed Description:

PHC facilities were eligible for the study if they were rural government owned; accessible by road during rainy season; and within 3 hours by car from Muhimbili University College of Health Sciences (MUCHS), Dar es Salaam

All children attending the 16 PHC facilities under the study during daytime were enrolled if they fulfilled the following criteria:

  1. below five years of age
  2. fever (temperature≥37.5◦C) and/or reported history of fever in last 2 days
  3. able to return to the facility on day 7 after treatment or any other day if symptoms were to worsen or recur
  4. the mother/guardian or caretaker consented to participate.

Patients with severe disease and/or general danger signs requiring inpatient care according to the IMCI guidelines were admitted or referred to the health centers or the district hospitals

  Eligibility

Ages Eligible for Study:   6 Months to 59 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. below five years of age
  2. fever (temperature≥37.5◦C) and/or reported history of fever in last 2 days
  3. able to return to the facility on day 7 after treatment or any other day if symptoms were to worsen or recur
  4. the mother/guardian or caretaker consented to participate

Exclusion Criteria:

a) N/A

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00687895

Locations
Tanzania
dispensaries/health centers in Kibaha and Bagamoyo
Coast, Tanzania
Sponsors and Collaborators
Muhimbili University of Health and Allied Sciences
Karolinska Institutet
Investigators
Study Director: Anders Bjorkman, MD Karolinska Institutet
  More Information

Publications:
Publications indexed to this study:
Responsible Party: Muhimbili University College of Health Sciences ( Zull Premji, professor )
Study ID Numbers: HF2003
Study First Received: May 28, 2008
Last Updated: May 28, 2008
ClinicalTrials.gov Identifier: NCT00687895  
Health Authority: Tanzania: National Institute for Medical Research

Keywords provided by Muhimbili University of Health and Allied Sciences:
malaria microscopy primary health care children

Study placed in the following topic categories:
Protozoan Infections
Benzocaine
Parasitic Diseases
Malaria

Additional relevant MeSH terms:
Coccidiosis

ClinicalTrials.gov processed this record on January 16, 2009